A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH

Clinical trial NCT03970031 · UNKNOWN

Trial details

NCT number: NCT03970031
Sponsor: Cirius Therapeutics, Inc.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Type2 Diabetes NASH - Nonalcoholic Steatohepatitis Nonalcoholic Steatohepatitis Non-Alcoholic Fatty Liver Disease

Start date: 2022-06-01
Primary completion: 2024-09-01
Enrollment: 1800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.